# A Cohort Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax Post Discharge for Ten Days

> **NCT00868179** · PHASE4 · WITHDRAWN · sponsor: **Ross Leighton**

## Conditions studied

- Thromboembolism

## Interventions

- **DRUG:** Pradax

## Key facts

- **NCT ID:** NCT00868179
- **Lead sponsor:** Ross Leighton
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-04
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study never started
- **Last updated:** 2022-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868179, "A Cohort Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax Post Discharge for Ten Days". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00868179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*